AKT3 and neoplasm: By binding the 3′-UTR of AKT3 and controlling AKT3 gene expression, miR-122 inhibits HCC cell proliferation, increases the chemosensitivity of HCC cells, and attenuates HCC tumor growth in vivo [67,68].